Maximize your thought leadership

For COPD Patients, an Unpredictable Disease Meets an Expanding Set of Treatment Options

By Advos•
A pulmonology nurse practitioner and a patient living with COPD highlight how persistent flare-ups can signal inadequately controlled disease and why conversations with healthcare providers about add-on treatments, including the biologic Dupixent, matter.
For COPD Patients, an Unpredictable Disease Meets an Expanding Set of Treatment Options

People living with inadequately controlled chronic obstructive pulmonary disease (COPD) face a daily uncertainty that can quietly erode the activities they value most. COPD is a chronic, progressive lung disease that can make breathing more difficult over time, and patients may experience ongoing coughing, increased mucus, wheezing, chest tightness or shortness of breath. Over time, these challenges can make it harder to fully engage in activities they enjoy, whether cheering at a rodeo, playing with grandchildren, cooking dinner or going for a walk.

Nurse practitioner Corinne Young, a pulmonology specialist who also competes in team roping events, draws a parallel between the disease and her sport. "People living with inadequately controlled COPD can experience an unpredictable life," she said. "They don't always know when difficulty with breathing might impact their daily activities." The comparison is more than rhetorical: in the rodeo, anything can happen in a matter of seconds, and for COPD patients a flare-up can arrive with similar suddenness.

The stakes for patients are concrete. Mark H., 60, has lived with COPD since 2010, and as his condition worsened it kept him from fully enjoying the things he loved. "I eventually had to step back from some of my favorite hobbies, and even had to retire from my job early, because the difficulty breathing wore me down," he recalled. "I remember feeling like, well, I guess this is my life now."

Clinicians say continuing to experience COPD flare-ups despite treatment may be a sign that the condition is inadequately controlled and a cue to talk to a healthcare professional about additional options. "I encourage my patients to talk about all symptoms they may be experiencing and how often COPD may be impacting their daily life so we can assess the full picture of their health," Young said. "Starting that conversation can help patients and their healthcare providers determine whether an add-on treatment may be appropriate."

Treatment options for COPD have expanded in recent years, and some patients may be candidates for a biologic such as Dupixent (dupilumab), developed by (Sanofi and Regeneron). DUPIXENT is a prescription medicine used with other medicines for the maintenance treatment of adults with inadequately controlled COPD and a high number of blood eosinophils, a type of white blood cell that may contribute to the disease. It is not used to relieve sudden breathing problems and will not replace an inhaled rescue medicine.

Young said some patients in her practice who added Dupixent to their COPD inhalers experienced reduced flare-ups, better breathing in as little as two weeks, and improvement in daily quality of life. Mark described a similar shift. "While everyone's experience is different, I felt like I noticed a difference after adding Dupixent," he said. "My breathing feels deeper, I don't feel as winded, and I'm doing more things I love." Patients seeking more information can visit Dupixent.com/COPD.

Safety information accompanies the treatment. DUPIXENT can cause serious side effects, including allergic reactions that can sometimes be severe and eye problems such as eye pain or changes in vision; some users have also reported joint aches and pain that in some cases required hospitalization. The most common side effects in patients with COPD include injection site reactions, common cold symptoms, a high count of a certain white blood cell, viral infection, back pain, nasal inflammation, diarrhea, stomach problems, joint pain, toothache, headache and urinary tract infection. Patients are encouraged to report negative side effects of prescription drugs to the FDA at www.fda.gov/medwatch.

Full Prescribing Information and Patient Information are available for patients and caregivers. For a condition defined by unpredictability, the central message is that persistent symptoms are worth raising with a healthcare provider, because an expanded treatment landscape may offer a path back to the activities patients thought they had lost.

Advos

Advos

@advos